bioRxiv · 10.1101/2022.12.20.521277
DeepGWAS: Enhance GWAS Signals for Neuropsychiatric Disorders via Deep Neural Network
Abstract
Genetic dissection of neuropsychiatric disorders can potentially reveal novel therapeutic targets. While genome-wide association studies (GWAS) have tremendously advanced our understanding, we approach a sample size bottleneck (i.e., the number of cases needed to identify >90% of all loci is impractical). Therefore, computationally enhancing GWAS on existing samples may be particularly valuable. Here, we describe DeepGWAS, a deep neural network-based method to enhance GWAS by integrating GWAS results with linkage disequilibrium and brain-related functional annotations. DeepGWAS enhanced schizophrenia (SCZ) loci by [~]3X when applied to the largest European GWAS, and 21.3% enhanced loci were validated by the latest multi-ancestry GWAS. Importantly, DeepGWAS models can be transferred to other neuropsychiatric disorders. Transferring SCZ-trained models to Alzheimers disease and major depressive disorder, we observed 1.3-17.6X detected loci compared to standard GWAS, among which 27-40% were validated by other GWAS studies. We anticipate DeepGWAS to be a powerful tool in GWAS studies.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Wen, J., Li, G., Chen, j., Sun, Q., Liu, W., Guan, W., Lai, B., Szatkiewicz, J. P., He, X., Sullivan, P. F., Li, Y.. 2022-12-21. DeepGWAS: Enhance GWAS Signals for Neuropsychiatric Disorders via Deep Neural Network. https://doi.org/10.1101/2022.12.20.521277
Cite the original work for its findings. Save a collection to share your selection of sources.